Erez Aminov's most recent trade in Mira Pharmaceuticals Inc was a trade of 83,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2026 | 83,500 | 83,500 | - | - | Restricted Stock Units | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | 31 Dec 2025 | 3,155,170 | 3,155,170 | - | - | Stock Options (right to buy) | ||
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 2.11 per share. | 31 Dec 2025 | 613,595 | 3,592,666 | - | 2.1 | 1,294,685 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 31 Dec 2025 | 379,000 | 4,206,259 | - | 0.8 | 318,360 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 379,000 | 379,000 | - | - | Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 31 Dec 2025 | 234,595 | 3,827,259 | - | 1.2 | 272,130 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 234,595 | 234,595 | - | - | Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 1.45 per share. | 31 Dec 2025 | 62,500 | 3,592,666 | - | 1.5 | 90,625 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 1.45 per share. | 31 Dec 2025 | 62,500 | 3,530,166 | - | 1.5 | 90,625 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 2,685,456 | 3,530,156 | - | - | Common Stock | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2025 | 150,000 | 150,000 | - | - | Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2025 | 150,000 | 150,000 | - | - | Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.37 per share. | 29 Aug 2025 | 62,500 | 844,700 | - | 1.4 | 85,625 | Common Stock |
| Telomir Pharma Inc | Erez Aminov | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 2,000,000 | 2,000,000 | - | - | Non-Qualified Options | |
| Telomir Pharma Inc | Erez Aminov | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 400,000 | 400,000 | - | - | Restricted Stock Units (RSUs) | |
| Telomir Pharma Inc | Erez Aminov | Director, CEO and Chairman | 31 Dec 2024 | 200 | 29,600 | - | 6.0 | 1,202 | Common Stock | |
| Telomir Pharma Inc | Erez Aminov | Director, CEO and Chairman | 31 Dec 2024 | 200 | 29,600 | - | 6.2 | 1,240 | Common Stock | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 2,000,000 | 2,000,000 | - | - | Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 500,000 | 500,000 | - | - | Restricted Stock Units | |
| Mira Pharma Inc | Aminov Erez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 19 Nov 2024 | 55,410 | 1,105,790 | - | 1.4 | 77,020 | Common Stock |
| Mira Pharma Inc | Aminov Erez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 19 Nov 2024 | 44,590 | 1,061,200 | - | 1.3 | 56,629 | Common Stock |
| Telomir Pharma Inc | Erez Aminov | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 1,960,170 | 1,960,170 | - | - | Incentive Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 379,000 | 629,000 | - | - | Incentive Stock Options (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 21 May 2024 | 2,000 | 379,000 | - | 0.8 | 1,680 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 21 May 2024 | 2,000 | 375,500 | - | 1 | 2,000 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 21 May 2024 | 1,000 | 376,500 | - | 1.0 | 1,030 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 21 May 2024 | 1,000 | 380,000 | - | 0.9 | 850 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 21 May 2024 | 800 | 382,200 | - | 1.0 | 776 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 21 May 2024 | 800 | 381,400 | - | 1.0 | 808 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 21 May 2024 | 600 | 380,600 | - | 0.9 | 522 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 21 May 2024 | 500 | 377,000 | - | 1.0 | 510 | Common Stock |
| Mira Pharma Inc | Erez Aminov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 300,000 | 250,000 | - | - | Incentive Stock Option (right to buy) | |
| Mira Pharma Inc | Erez Aminov | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 150,000 | 150,000 | - | - | Stock Options |